These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34652445)

  • 1. Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial.
    Dinh A; Duran C; Ropers J; Bouchand F; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Mellon G; Calin R; Makhloufi S; de Lastours V; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Guillemot D; Renaud B; Claessens YE; Labarère J; Aegerter P; Bedos JP; Crémieux AC;
    JAMA Netw Open; 2021 Oct; 4(10):e2129566. PubMed ID: 34652445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
    Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC;
    Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial.
    Dinh A; Duran C; Ropers J; Bouchand F; Deconinck L; Matt M; Senard O; Lagrange A; Mellon G; Calin R; Makhloufi S; de Lastours V; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC;
    Clin Microbiol Infect; 2024 Aug; 30(8):1020-1028. PubMed ID: 38734138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.
    Bielicki JA; Stöhr W; Barratt S; Dunn D; Naufal N; Roland D; Sturgeon K; Finn A; Rodriguez-Ruiz JP; Malhotra-Kumar S; Powell C; Faust SN; Alcock AE; Hall D; Robinson G; Hawcutt DB; Lyttle MD; Gibb DM; Sharland M;
    JAMA; 2021 Nov; 326(17):1713-1724. PubMed ID: 34726708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
    Uranga A; España PP; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; Tomás L; Camino J; Nuñez J; Capelastegui A
    JAMA Intern Med; 2016 Sep; 176(9):1257-65. PubMed ID: 27455166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.
    Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A
    JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial.
    Pernica JM; Harman S; Kam AJ; Carciumaru R; Vanniyasingam T; Crawford T; Dalgleish D; Khan S; Slinger RS; Fulford M; Main C; Smieja M; Thabane L; Loeb M
    JAMA Pediatr; 2021 May; 175(5):475-482. PubMed ID: 33683325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate Diagnosis of Pneumonia Among Hospitalized Adults.
    Gupta AB; Flanders SA; Petty LA; Gandhi TN; Pulia MS; Horowitz JK; Ratz D; Bernstein SJ; Malani AN; Patel PK; Hofer TP; Basu T; Chopra V; Vaughn VM
    JAMA Intern Med; 2024 May; 184(5):548-556. PubMed ID: 38526476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.
    Torres A; Sibila O; Ferrer M; Polverino E; Menendez R; Mensa J; Gabarrús A; Sellarés J; Restrepo MI; Anzueto A; Niederman MS; Agustí C
    JAMA; 2015 Feb; 313(7):677-86. PubMed ID: 25688779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.
    Li Q; Zhou Q; Florez ID; Mathew JL; Shang L; Zhang G; Tian X; Fu Z; Liu E; Luo Z; Chen Y
    JAMA Pediatr; 2022 Dec; 176(12):1199-1207. PubMed ID: 36374480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-Acquired Pneumonia in Patients With Diabetes Mellitus: Predictors of Complications and Length of Hospital Stay.
    Bader MS; Yi Y; Abouchehade K; Haroon B; Bishop LD; Hawboldt J
    Am J Med Sci; 2016 Jul; 352(1):30-5. PubMed ID: 27432032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial.
    Williams DJ; Creech CB; Walter EB; Martin JM; Gerber JS; Newland JG; Howard L; Hofto ME; Staat MA; Oler RE; Tuyishimire B; Conrad TM; Lee MS; Ghazaryan V; Pettigrew MM; Fowler VG; Chambers HF; Zaoutis TE; Evans S; Huskins WC;
    JAMA Pediatr; 2022 Mar; 176(3):253-261. PubMed ID: 35040920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CCERW: a new rule to predict treatment failure in patients with community-acquired pneumonia in middle aged and elderly people].
    Li JS; Li SY; Yu XQ; Sun ZK; Zhang W; Jia XH; Zheng SP; Wang MH; Wang HF
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jan; 23(1):10-7. PubMed ID: 21251359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Avoidable 30-Day Readmissions Following Hospitalization for Community-Acquired Pneumonia in France.
    Boussat B; Cazzorla F; Le Marechal M; Pavese P; Mounayar AL; Sellier E; Gaillat J; Camara B; Degano B; Maillet M; Courtois X; Bouisse M; Seigneurin A; François P
    JAMA Netw Open; 2022 Apr; 5(4):e226574. PubMed ID: 35394509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-Acquired Pneumonia and Risk of Cardiovascular Events in People Living With HIV.
    Zifodya JS; Duncan MS; So-Armah KA; Attia EF; Akgün KM; Rodriguez-Barradas MC; Marconi VC; Budoff MJ; Bedimo RJ; Alcorn CW; Soo Hoo GW; Butt AA; Kim JW; Sico JJ; Tindle HA; Huang L; Tate JP; Justice AC; Freiberg MS; Crothers K
    J Am Heart Assoc; 2020 Dec; 9(23):e017645. PubMed ID: 33222591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence and risk factors for cardiovascular events in patients hospitalized with community-acquired pneumonia].
    Chen L; Han XD; Li YL; Zhang CX; Xing XQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Mar; 48(3):228-235. PubMed ID: 32234181
    [No Abstract]   [Full Text] [Related]  

  • 18. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P; File T; Feldman C
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy and the risk for community-acquired pneumonia.
    Gau JT; Acharya U; Khan S; Heh V; Mody L; Kao TC
    BMC Geriatr; 2010 Jul; 10():45. PubMed ID: 20604960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia.
    Garin N; Felix G; Chuard C; Genné D; Carballo S; Hugli O; Lamy O; Marti C; Nendaz M; Rutschmann O; Harbarth S; Perrier A
    PLoS One; 2016; 11(6):e0157350. PubMed ID: 27305046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.